As of December 2024, Theriva Biologics has a market cap of $67.32M. This makes Theriva Biologics the world's 23493th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $8.01M | 9.30% |
2023 | $7.33M | -4.44% |
2022 | $7.67M | -83.33% |
2021 | $46.02M | -28.95% |
2020 | $64.76M | -25.49% |
2019 | $86.92M | -8.93% |
2018 | $95.44M | -96.86% |
2017 | $3.04B | -32.89% |
2016 | $4.53B | -66.81% |
2015 | $13.66B | 56.85% |
2014 | $8.71B | -4.58% |
2013 | $9.13B | -13.07% |
2012 | $10.50B | 39.68% |
2011 | $7.52B | 0.80% |
2010 | $7.46B | 123.21% |
2009 | $3.34B | 211.11% |
2008 | $1.07B | -96.48% |
2007 | $30.54B | -70.32% |
2006 | $102.90B | - |